Anthony Letai
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Cell death mechanisms and regulation 61
- RNA Interference and Gene Delivery 26
- Protein Degradation and Inhibitors 15
- Oncology 51
- Cancer-related Molecular Pathways 16
- Co-authors
- Kristopher A. Sarosiek (15 shared papers)Rumani Singh (2 shared papers)Stanley J. Korsmeyer (4 shared papers)Joslyn K. Brunelle (4 shared papers)Victoria Del Gaizo Moore (6 shared papers)Jeremy Ryan (43 shared papers)Loren D. Walensky (2 shared papers)Michael Certo (3 shared papers)
- Journals
- Blood (47 papers)Cancer Research (14 papers)Cancer Cell (8 papers)Proceedings of the National Academy of Sciences (6 papers)Blood Advances (5 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Anthony Letai
184 papers receiving 18.6k citations
Anthony Letai's Hit Papers
Peers
Comparison fields: 5 of 161
- Hematology 3.6k
- Genetics 1.9k
- Molecular Biology 11.7k
- Oncology 4.2k
- Cancer Research 1.9k
Countries citing papers authored by Anthony Letai
This map shows the geographic impact of Anthony Letai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Letai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Letai more than expected).
Fields of papers citing papers by Anthony Letai
This network shows the impact of papers produced by Anthony Letai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Letai. The network helps show where Anthony Letai may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Letai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins Hit paper breakdown → | 2019 | 1553 |
| 2 | Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics Hit paper breakdown → | 2002 | 1306 |
| 3 | Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia Hit paper breakdown → | 2018 | 1210 |
| 4 | Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members Hit paper breakdown → | 2006 | 996 |
| 5 | Control of mitochondrial apoptosis by the Bcl-2 family Hit paper breakdown → | 2009 | 761 |
| 6 | Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1 Hit paper breakdown → | 2003 | 665 |
| 7 | A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib Hit paper breakdown → | 2005 | 561 |
| 8 | Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study Hit paper breakdown → | 2018 | 508 |
| 9 | 2007 | 474 | |
| 10 | 2008 | 449 | |
| 11 | Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages Hit paper breakdown → | 2017 | 441 |
| 12 | 2015 | 409 | |
| 13 | 2007 | 388 | |
| 14 | 2010 | 293 | |
| 15 | 2012 | 271 | |
| 16 | 2016 | 265 | |
| 17 | 2015 | 253 | |
| 18 | 2016 | 220 | |
| 19 | 2008 | 215 | |
| 20 | 2017 | 214 |
About Anthony Letai
Anthony Letai is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Genetics, having authored 186 papers that have together received 18.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (61 papers), Acute Myeloid Leukemia Research (30 papers), Chronic Lymphocytic Leukemia Research (30 papers), RNA Interference and Gene Delivery (26 papers), Phagocytosis and Immune Regulation (17 papers), Acute Lymphoblastic Leukemia research (16 papers), Cancer-related Molecular Pathways (16 papers) and Protein Degradation and Inhibitors (15 papers). The work is most often cited by research in Hematology (3.6k citations), Genetics (1.9k citations), Molecular Biology (11.7k citations), Oncology (4.2k citations) and Cancer Research (1.9k citations). Anthony Letai has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Kristopher A. Sarosiek, Rumani Singh, Stanley J. Korsmeyer, Joslyn K. Brunelle, Victoria Del Gaizo Moore, Jeremy Ryan, Loren D. Walensky, Michael Certo, Solly Weiler and Michael C. Bassik. Their work appears in journals such as Blood, Cancer Research, Cancer Cell, Proceedings of the National Academy of Sciences and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.